Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 20;24(6):1100.
doi: 10.3390/molecules24061100.

Identification of Bis-Cyclic Guanidines as Antiplasmodial Compounds from Positional Scanning Mixture-Based Libraries

Affiliations

Identification of Bis-Cyclic Guanidines as Antiplasmodial Compounds from Positional Scanning Mixture-Based Libraries

David L Perry Jr et al. Molecules. .

Abstract

The screening of more than 30 million compounds derived from 81 small molecule libraries built on 81 distinct scaffolds identified pyrrolidine bis-cyclic guanidine library (TPI-1955) to be one of the most active and selective antiplasmodial libraries. The screening of the positional scanning library TPI-1955 arranged on four sets of sublibraries (26 + 26 + 26 + 40), totaling 120 samples for testing provided information about the most important groups of each variable position in the TPI-1955 library containing 738,192 unique compounds. The parallel synthesis of the individual compounds derived from the deconvolution of the positional scanning library led to the identification of active selective antiplasmodial pyrrolidine bis-cyclic guanidines.

Keywords: antiplasmodial; combinatorial chemistry; guanidines; heterocyclic peptidomimetics; malaria; parallel synthesis; solid-phase synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Screening of scaffold ranking library for antiplasmodial activity.
Figure 2
Figure 2
Deconvolution of positional scanning pyrrolidine bis-cyclic guanidine library TPI-1955 and synthesis of individual compounds TPI-2359.
Scheme 1
Scheme 1
Synthesis of pyrrolidine bis-cyclic guanidines from resin-bound acylated tetrapeptides.
Figure 3
Figure 3
Identification of active groups at positions R1–R4 in the compound mixture.
Figure 4
Figure 4
Structures and activity of identified top antiplasmodial hits.
Figure 5
Figure 5
Stage-specific inhibition of Plasmodium growth by TPI 2359-47. Tightly synchronized parasites were treated at 6-h post-invasion of merozoites with 5 × EC50 concentration of the chemotype. (A) Microscopic evaluation of Giemsa-stained thin smears in the left. Histogram plot of YOYO-1 labeled cells following treatment of the compound were shown in the right. (B) Distribution of developmental stages at different time intervals following treatment of the compound at 6 h postinvasion. Three replicates of 1000 parasitized erythrocytes were counted to determine stage-specific distribution. DHA, dihydroartemisinin.
Figure 6
Figure 6
Stage-specific inhibition of Plasmodium growth by TPI 2359-47. (A) Microscopic evaluation of Giemsa-stained thin smears and flow cytometric analysis of the YOYO-1-labeled cells to measure DNA content when the culture was exposed to the inhibitor (5 × EC50) at 30 h postinvasion. (B) Distribution of different stages when the culture was treated at 30 h postinvasion. (C,D) Effect following exposure of the parasite to the compound at 42 h postinvasion. Three replicates of 1000 parasitized erythrocytes were counted to determine stage-specific distribution. DHA, dihydroartemisinin.

Similar articles

Cited by

References

    1. Murray C.J., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., Fullman N., Naghavi M., Lozano R., Lopez A.D. Global malaria mortality between 1980 and 2010: A systematic analysis. Lancet. 2012;379:413–431. doi: 10.1016/S0140-6736(12)60034-8. - DOI - PubMed
    1. Grimberg B.T., Mehlotra R.K. Expanding the Antimalarial Drug Arsenal-Now, But How? Pharmaceuticals. 2011;4:681–712. doi: 10.3390/ph4050681. - DOI - PMC - PubMed
    1. Cui W. WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance. BMJ. 2011;342:d2793. doi: 10.1136/bmj.d2793. - DOI - PubMed
    1. Ashley E.A., Dhorda M., Fairhurst R.M., Amaratunga C., Lim P., Suon S., Sreng S., Anderson J.M., Mao S., Sam B., et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. - DOI - PMC - PubMed
    1. Li J.W., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325:161–165. doi: 10.1126/science.1168243. - DOI - PubMed

LinkOut - more resources